HER2-positive Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06366 | Pertuzumab | 1 | Completed | 1 |
| DB14967 | Margetuximab | Not Available | Approved for Marketing | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06366 | Pertuzumab | 1 | Completed | 1 |
| DB14967 | Margetuximab | Not Available | Approved for Marketing | 1 |